首页 > 最新文献

Precision Medical Sciences最新文献

英文 中文
Platelets, mean platelet volume, lymphocytes, leukocytes, and ratios of them altered in patients with hepatitis B virus‐related decompensated cirrhosis 乙型肝炎病毒相关失代偿期肝硬化患者的血小板、平均血小板体积、淋巴细胞、白细胞及其比率变化
IF 0.5 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2022-06-01 DOI: 10.1002/prm2.12070
Changzhi Xu, Yanhua Yi, Zhizhi Xie, Donglin Zhu, Dannier Abuduwaili, Zhu Wang, Yun Xi
Blood routine examination is an inexpensive, routinely performed clinical project, which includes many blood parameters. Hepatitis B virus (HBV) infection may have significant effects on blood parameters in decompensated patients with hepatitis B cirrhosis. However, details were not quite clear yet. A total of 207 HBV‐related decompensated cirrhosis (HBV‐DeCi) patients were included in this retrospective analysis. The included patients were subdivided into three groups: 44 patients with HBsAg, HBeAg, and HbcAb positive were set as Group I; 122 patients with HBsAg, HBeAb, and HbcAb positive were set as Group II; 41 patients with HBsAb, HBeAb, and HbcAb positive were set as Group III. Blood parameters, including platelet (PLT) count, mean platelet volume (MPV), lymphocyte count, leukocyte count and MPV/lymphocyte ratio (MPVLR), lymphocyte/ leukocyte ratio (LLR), platelet/leukocyte ratio (PLR) were analyzed respectively. The correlation between mentioned parameters and the HBV infection were characterized respectively. The values of PLT, MPVLR, and PLR in Group I and II were lower than that in Group III. Group II has a much higher LLR than that in Group I and III. HBV does have significantly effect on blood parameters in HBV‐DeCi patients. Effective treatment must be applied to achieve cirrhosis recompensation promptly.
血常规检查是一项廉价的常规临床项目,包括许多血液参数。乙型肝炎病毒(HBV)感染可能对乙型肝炎肝硬化失代偿期患者的血液参数产生显著影响。然而,细节还不太清楚。本回顾性分析共纳入207名HBV相关失代偿性肝硬化(HBV‐DeCi)患者。纳入的患者被分为三组:44例HBsAg、HBeAg和HbcAb阳性的患者被设为第一组;将122例HBsAg、HBeAb和HbcAb阳性患者设为II组;将41例HBsAb、HBeAb和HbcAb阳性患者设为第三组。分别分析血液参数,包括血小板(PLT)计数、平均血小板体积(MPV)、淋巴细胞计数、白细胞计数和MPV/淋巴细胞比值(MPVLR)、淋巴细胞/白细胞比值(LLR)、血小板/白细胞比率(PLR)。分别对上述参数与HBV感染的相关性进行了表征。I组和II组的PLT、MPVLR和PLR值低于III组。II组的LLR远高于I组和III组。HBV确实对HBV-DeCi患者的血液参数有显著影响。必须采取有效的治疗方法,及时实现肝硬化的代偿。
{"title":"Platelets, mean platelet volume, lymphocytes, leukocytes, and ratios of them altered in patients with hepatitis B virus‐related decompensated cirrhosis","authors":"Changzhi Xu, Yanhua Yi, Zhizhi Xie, Donglin Zhu, Dannier Abuduwaili, Zhu Wang, Yun Xi","doi":"10.1002/prm2.12070","DOIUrl":"https://doi.org/10.1002/prm2.12070","url":null,"abstract":"Blood routine examination is an inexpensive, routinely performed clinical project, which includes many blood parameters. Hepatitis B virus (HBV) infection may have significant effects on blood parameters in decompensated patients with hepatitis B cirrhosis. However, details were not quite clear yet. A total of 207 HBV‐related decompensated cirrhosis (HBV‐DeCi) patients were included in this retrospective analysis. The included patients were subdivided into three groups: 44 patients with HBsAg, HBeAg, and HbcAb positive were set as Group I; 122 patients with HBsAg, HBeAb, and HbcAb positive were set as Group II; 41 patients with HBsAb, HBeAb, and HbcAb positive were set as Group III. Blood parameters, including platelet (PLT) count, mean platelet volume (MPV), lymphocyte count, leukocyte count and MPV/lymphocyte ratio (MPVLR), lymphocyte/ leukocyte ratio (LLR), platelet/leukocyte ratio (PLR) were analyzed respectively. The correlation between mentioned parameters and the HBV infection were characterized respectively. The values of PLT, MPVLR, and PLR in Group I and II were lower than that in Group III. Group II has a much higher LLR than that in Group I and III. HBV does have significantly effect on blood parameters in HBV‐DeCi patients. Effective treatment must be applied to achieve cirrhosis recompensation promptly.","PeriodicalId":40071,"journal":{"name":"Precision Medical Sciences","volume":"11 1","pages":"46 - 50"},"PeriodicalIF":0.5,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46324275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preoperative prediction of lymphovascular invasion of CRC by artificial neural network 应用人工神经网络预测结直肠癌淋巴血管侵袭
IF 0.5 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2022-06-01 DOI: 10.1002/prm2.12074
Dejun Wu, Zhou Yang, Leilei Sun, Yingjun Quan, Zhi-jun Min
Lymphovascular invasion (LVI) was considered to be important for metastasis of colorectal cancer (CRC). However, there was still no effective method to predict LVI before operation. Our research aimed to construct an artificial neural network (ANN) for the preoperative prediction of LVI. We obtained blood indexes and condition of LVI (confirmed by pathological examination) of 288 cases of CRC patients from a tertiary hospital in China. One hundred and eighty‐five CRC patients (training group) were randomly selected to establish neural network and logistic regression models. The remaining 103 cases of CRC patients received the test of ANN and logistic model (validation group). Receiver operating characteristics curve (ROC) and decision curve analysis (DCA) were performed to assess the accuracy of constructed model respectively. All procedures involving human participants were performed by the Shanghai Pudong Hospital ethical committee (2020 No. W2‐007) and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. All patients provided their written informed consent. In the training group, the area under the curve (AUC) of ANN was higher than that of the logistic model (0.832 vs 0.692). The ANN correctly predicted 92% cases of LVI, whereas the logistic model only predicted 56% cases. Similar results were also tested in the validation model. Our constructed ANN showed higher accuracy compared with the conventional linear model. The ANN‐based on blood indexes may provide value for preoperative prediction of LVI.
淋巴血管侵犯(LVI)被认为是癌症(CRC)转移的重要因素。然而,目前还没有有效的方法预测术前LVI。我们的研究旨在构建一种用于LVI术前预测的人工神经网络(ANN)。对我国某三级医院288例结直肠癌患者的血液指标和LVI(经病理证实)情况进行了分析。随机选择185名CRC患者(训练组)建立神经网络和逻辑回归模型。其余103例CRC患者接受了ANN和logistic模型的检验(验证组)。分别进行受试者操作特征曲线(ROC)和决策曲线分析(DCA)来评估所构建模型的准确性。所有涉及人类参与者的程序均由上海浦东医院伦理委员会(2020编号W2‐007)执行,并符合1964年《赫尔辛基宣言》及其后来的修正案或类似的伦理标准。所有患者都提供了书面知情同意书。在训练组中,ANN的曲线下面积(AUC)高于logistic模型(0.832vs 0.692)。ANN正确预测了92%的LVI病例,而logistic模型仅预测了56%的病例。在验证模型中也测试了类似的结果。与传统的线性模型相比,我们构建的人工神经网络具有更高的精度。基于血液指标的人工神经网络可能为LVI的术前预测提供价值。
{"title":"Preoperative prediction of lymphovascular invasion of CRC by artificial neural network","authors":"Dejun Wu, Zhou Yang, Leilei Sun, Yingjun Quan, Zhi-jun Min","doi":"10.1002/prm2.12074","DOIUrl":"https://doi.org/10.1002/prm2.12074","url":null,"abstract":"Lymphovascular invasion (LVI) was considered to be important for metastasis of colorectal cancer (CRC). However, there was still no effective method to predict LVI before operation. Our research aimed to construct an artificial neural network (ANN) for the preoperative prediction of LVI. We obtained blood indexes and condition of LVI (confirmed by pathological examination) of 288 cases of CRC patients from a tertiary hospital in China. One hundred and eighty‐five CRC patients (training group) were randomly selected to establish neural network and logistic regression models. The remaining 103 cases of CRC patients received the test of ANN and logistic model (validation group). Receiver operating characteristics curve (ROC) and decision curve analysis (DCA) were performed to assess the accuracy of constructed model respectively. All procedures involving human participants were performed by the Shanghai Pudong Hospital ethical committee (2020 No. W2‐007) and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. All patients provided their written informed consent. In the training group, the area under the curve (AUC) of ANN was higher than that of the logistic model (0.832 vs 0.692). The ANN correctly predicted 92% cases of LVI, whereas the logistic model only predicted 56% cases. Similar results were also tested in the validation model. Our constructed ANN showed higher accuracy compared with the conventional linear model. The ANN‐based on blood indexes may provide value for preoperative prediction of LVI.","PeriodicalId":40071,"journal":{"name":"Precision Medical Sciences","volume":"11 1","pages":"62 - 68"},"PeriodicalIF":0.5,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45689920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The analysis of the circRNAs in the progress of acquired resistance to Cetuximab 西妥昔单抗获得性耐药进展中的环状rna分析
IF 0.5 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2022-06-01 DOI: 10.1002/prm2.12066
Liping Yin, Changwen Jing, Yesong Guo
We established a Cetuximab‐resistant cell lines by high‐dose pulse method and searched for differentially expressed circular RNAs by RNA sequencing. Hundreds of circRNAs were altered between sensitive and resistant cells. Next, we chose six notably differential circRNAs and conducted quantitative real‐time PCR by specific primers. Kyoto Encyclopedia of Genes and Genomes pathway analysis revealed that differentially expressed circular RNAs are enriched in some tumor‐related pathways, such as tumor transcription regulation, metabolism, PI3K‐Akt, mTOR, and other signaling pathways. Our results explored differentially expressed circular RNAs associated with Cetuximab to find new targets for Cetuximab resistance therapy.
我们采用高剂量脉冲法建立了西妥昔单抗耐药细胞系,并通过RNA测序寻找差异表达的环状RNA。数百个环状rna在敏感细胞和耐药细胞之间发生了改变。接下来,我们选择了六个显著差异的环状rna,并通过特定引物进行了定量实时PCR。京都基因和基因组百科全书通路分析显示,差异表达的环状rna在一些肿瘤相关通路中富集,如肿瘤转录调节、代谢、PI3K - Akt、mTOR等信号通路。我们的研究结果探索了与西妥昔单抗相关的差异表达环状rna,以寻找西妥昔单抗耐药治疗的新靶点。
{"title":"The analysis of the circRNAs in the progress of acquired resistance to Cetuximab","authors":"Liping Yin, Changwen Jing, Yesong Guo","doi":"10.1002/prm2.12066","DOIUrl":"https://doi.org/10.1002/prm2.12066","url":null,"abstract":"We established a Cetuximab‐resistant cell lines by high‐dose pulse method and searched for differentially expressed circular RNAs by RNA sequencing. Hundreds of circRNAs were altered between sensitive and resistant cells. Next, we chose six notably differential circRNAs and conducted quantitative real‐time PCR by specific primers. Kyoto Encyclopedia of Genes and Genomes pathway analysis revealed that differentially expressed circular RNAs are enriched in some tumor‐related pathways, such as tumor transcription regulation, metabolism, PI3K‐Akt, mTOR, and other signaling pathways. Our results explored differentially expressed circular RNAs associated with Cetuximab to find new targets for Cetuximab resistance therapy.","PeriodicalId":40071,"journal":{"name":"Precision Medical Sciences","volume":"11 1","pages":"51 - 55"},"PeriodicalIF":0.5,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48326581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of ear exercises on hearing loss in patients with nasopharyngeal carcinoma after radiotherapy 耳操对鼻咽癌放疗后听力损失的影响
IF 0.5 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2022-06-01 DOI: 10.1002/prm2.12073
Juan Lu, Hui Zhang, D. Xu, Lingyun Shi, Jing Wen
The objective of the study is to explore the effect of an ear health exercise on hearing loss of patients with nasopharyngeal carcinoma receiving radiotherapy. One hundred and seventeen patients diagnosed with nasopharyngeal carcinoma from June 2018 to January 2020 were selected as research subjects randomly divided into three groups. Thirty‐eight cases were in experimental group 1 and given an ear health exercise for 6 months, 38 cases were in experimental group 2 and given an ear health exercise for 12 months, and 41 cases in control group only received hearing health education. The hearing loss of three groups was compared before intervention and at 6 and 12 months after intervention. The value of the average audibility threshold of air conduction, the occurrence rate of abnormal acoustic immittance (ear), the rate of tympanic cavity effusion, and occur rate of secretory otitis media in two experimental groups were lower than control group among different time points. The above indicators of experimental group 2 were lower than those of group 1 (p < .05). The total effective rate of hearing improvement in experimental groups 1 and 2 was higher than that of control group after the intervention. Besides, the total effective rate in experimental group 2 was higher than that in group 1, and the difference was statistically significant (p < .05). There was no serious adverse reaction. An ear health exercise can reduce hearing loss of patients with nasopharyngeal carcinoma receiving radiotherapy. It can be used as daily rehabilitation measures to prevent or delay hearing loss for these patients.
本研究的目的是探讨耳保健操对鼻咽癌放疗患者听力损失的影响。选择2018年6月至2020年1月诊断为鼻咽癌的117名患者作为研究对象,随机分为三组。38例在实验组1中进行了6个月的耳朵健康锻炼,38例在试验组2中进行了12个月的耳部健康锻炼,41例在对照组中只接受了听力健康教育。比较干预前和干预后6个月和12个月三组的听力损失。在不同时间点,两个实验组的空气传导平均可听阈值、异常导抗(耳)发生率、鼓室积液率和分泌性中耳炎发生率均低于对照组。实验组2的上述指标低于实验组1(p < .05)。干预后,实验组1和2的听力改善总有效率高于对照组。实验2组总有效率高于实验1组,差异有统计学意义(p < .05)。无严重不良反应。耳健康锻炼可以减少鼻咽癌放疗患者的听力损失。它可以作为日常康复措施,预防或延迟这些患者的听力损失。
{"title":"Effect of ear exercises on hearing loss in patients with nasopharyngeal carcinoma after radiotherapy","authors":"Juan Lu, Hui Zhang, D. Xu, Lingyun Shi, Jing Wen","doi":"10.1002/prm2.12073","DOIUrl":"https://doi.org/10.1002/prm2.12073","url":null,"abstract":"The objective of the study is to explore the effect of an ear health exercise on hearing loss of patients with nasopharyngeal carcinoma receiving radiotherapy. One hundred and seventeen patients diagnosed with nasopharyngeal carcinoma from June 2018 to January 2020 were selected as research subjects randomly divided into three groups. Thirty‐eight cases were in experimental group 1 and given an ear health exercise for 6 months, 38 cases were in experimental group 2 and given an ear health exercise for 12 months, and 41 cases in control group only received hearing health education. The hearing loss of three groups was compared before intervention and at 6 and 12 months after intervention. The value of the average audibility threshold of air conduction, the occurrence rate of abnormal acoustic immittance (ear), the rate of tympanic cavity effusion, and occur rate of secretory otitis media in two experimental groups were lower than control group among different time points. The above indicators of experimental group 2 were lower than those of group 1 (p < .05). The total effective rate of hearing improvement in experimental groups 1 and 2 was higher than that of control group after the intervention. Besides, the total effective rate in experimental group 2 was higher than that in group 1, and the difference was statistically significant (p < .05). There was no serious adverse reaction. An ear health exercise can reduce hearing loss of patients with nasopharyngeal carcinoma receiving radiotherapy. It can be used as daily rehabilitation measures to prevent or delay hearing loss for these patients.","PeriodicalId":40071,"journal":{"name":"Precision Medical Sciences","volume":"11 1","pages":"87 - 94"},"PeriodicalIF":0.5,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45907502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Issue Information 问题信息
IF 0.5 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2022-06-01 DOI: 10.1002/prm2.12045
{"title":"Issue Information","authors":"","doi":"10.1002/prm2.12045","DOIUrl":"https://doi.org/10.1002/prm2.12045","url":null,"abstract":"","PeriodicalId":40071,"journal":{"name":"Precision Medical Sciences","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49270341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of miR‐34b/c rs4938723 T > C on pediatric glioma susceptibility miR - 34b/c rs4938723 T > c对小儿胶质瘤易感性的影响
IF 0.5 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2022-06-01 DOI: 10.1002/prm2.12067
Xingyu Jia, Wenchao Chen, Wei Chen, Yuxiang Liao, Jing Zhou, L. Yuan, Huiran Lin, Jun Bian
Gliomas, the most common type of primary intracranial tumor, arise from the brain's glial cells and constitute 30% of all brain and central nervous system tumors. MiR‐34b/c plays an important role in colorectal cancer and other cancers, but its role in glioma is unknown. In this study, we attempted to assess the effect of rs4938723 T > C in miR‐34b/c on the susceptibility of glioma Chinese children. Odds ratios and 95% confidence intervals (CIs) were calculated to evaluate the association between the selected polymorphism and glioma susceptibility. Our results showed that there is no significant association between this polymorphism and the risk of glioma in Chinese children. However, stratified analysis showed that the rs4938723 TC/CC genotype significantly reduced the risk of glioma in participants under 60 months of age (adjusted OR = 0.56, 95% CI = 0.35–0.88, p = .013). Overall, our study indicates that miR‐34b/c rs4938723 T > C polymorphism may have a weak influence on glioma susceptibility. Nevertheless, these findings need to be validated in well‐designed studies with larger sample sizes and different populations.
胶质瘤是最常见的原发性颅内肿瘤,起源于大脑的胶质细胞,占所有脑和中枢神经系统肿瘤的30%。MiR - 34b/c在结直肠癌和其他癌症中发挥重要作用,但在胶质瘤中的作用尚不清楚。在这项研究中,我们试图评估miR - 34b/ C中rs4938723 T > C对中国儿童胶质瘤易感性的影响。计算比值比和95%置信区间(ci)来评估所选多态性与胶质瘤易感性之间的关联。我们的研究结果显示,这种多态性与中国儿童患胶质瘤的风险之间没有显著的关联。然而,分层分析显示,rs4938723 TC/CC基因型显著降低了60月龄以下参与者发生胶质瘤的风险(调整后OR = 0.56, 95% CI = 0.35-0.88, p = 0.013)。总之,我们的研究表明miR - 34b/c rs4938723 T > c多态性可能对胶质瘤易感性有微弱的影响。然而,这些发现需要在设计良好的研究中进行验证,这些研究需要更大的样本量和不同的人群。
{"title":"Effect of miR‐34b/c rs4938723 T > C on pediatric glioma susceptibility","authors":"Xingyu Jia, Wenchao Chen, Wei Chen, Yuxiang Liao, Jing Zhou, L. Yuan, Huiran Lin, Jun Bian","doi":"10.1002/prm2.12067","DOIUrl":"https://doi.org/10.1002/prm2.12067","url":null,"abstract":"Gliomas, the most common type of primary intracranial tumor, arise from the brain's glial cells and constitute 30% of all brain and central nervous system tumors. MiR‐34b/c plays an important role in colorectal cancer and other cancers, but its role in glioma is unknown. In this study, we attempted to assess the effect of rs4938723 T > C in miR‐34b/c on the susceptibility of glioma Chinese children. Odds ratios and 95% confidence intervals (CIs) were calculated to evaluate the association between the selected polymorphism and glioma susceptibility. Our results showed that there is no significant association between this polymorphism and the risk of glioma in Chinese children. However, stratified analysis showed that the rs4938723 TC/CC genotype significantly reduced the risk of glioma in participants under 60 months of age (adjusted OR = 0.56, 95% CI = 0.35–0.88, p = .013). Overall, our study indicates that miR‐34b/c rs4938723 T > C polymorphism may have a weak influence on glioma susceptibility. Nevertheless, these findings need to be validated in well‐designed studies with larger sample sizes and different populations.","PeriodicalId":40071,"journal":{"name":"Precision Medical Sciences","volume":"11 1","pages":"82 - 86"},"PeriodicalIF":0.5,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42050862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
C‐reactive protein to LymphocytE count ratio could be a reliable mArkeR of thyroiditis; the CLEAR‐T study C反应蛋白与淋巴细胞计数比值可作为甲状腺炎的可靠指标CLEAR‐T研究
IF 0.5 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2022-03-01 DOI: 10.1002/prm2.12065
M. Demirkol, G. Aktas
Inflammation of the thyroid gland is referred to as thyroiditis and is associated with inflammation. Recent studies found significant association between thyroiditis and novel inflammatory and metabolic markers, as well as C‐reactive protein (CRP). CRP/lymphocyte count ratio (CLR) is a novel inflammatory marker that associated with various conditions and has not been studied in thyroiditis, yet. We aimed to investigate CRP to lymphocyte count ratio in patients with thyroiditis and to compare to those in healthy subjects. Patients with thyroiditis that presented to internal medicine outpatient clinics of our institution between January 2019 and August 2021 were enrolled to the retrospective study. Healthy volunteers were enrolled as control group. CLR of the thyroiditis and control groups were compared. Median CLR of the thyroiditis and control groups were 3.14 (0.14%–38)% and 0.4 (0.03–8.86)%, respectively (p < .001). The sensitivity and specificity of CLR > 0.43% in detecting thyroiditis were 92% and 58%, respectively (AUC: 0.88, p < .001, 95% CI: 0.85–0.92).CLR was significantly and positively correlated with free T4 (FT4) (r = .18, p < .001) and inversely correlated with thyroid stimulating hormone (TSH) (r = −.52, p = .003) levels. In conclusion, we suggest that high CLR levels may yield additional diagnostic value in patients with thyroiditis.
甲状腺炎症被称为甲状腺炎,与炎症有关。最近的研究发现甲状腺炎与新的炎症和代谢标志物以及C反应蛋白(CRP)之间存在显著关联。CRP/淋巴细胞计数比(CLR)是一种新的炎症标志物,与各种疾病有关,尚未在甲状腺炎中进行研究。我们旨在研究甲状腺炎患者的CRP与淋巴细胞计数的比率,并与健康受试者进行比较。2019年1月至2021年8月期间在我院内科门诊就诊的甲状腺炎患者被纳入回顾性研究。健康志愿者作为对照组。比较甲状腺炎组和对照组的CLR。甲状腺炎组和对照组的中位CLR分别为3.14(0.14%-38)%和0.4(0.03-8.86)%(p  检测甲状腺炎的0.43%分别为92%和58%(AUC:0.88,p < .001,95%CI:0.85-0.92)。CLR与游离T4(FT4)呈显著正相关(r=.18,p < .001)与促甲状腺激素(TSH)水平呈负相关(r=−.52,p=.003)。总之,我们认为高CLR水平可能对甲状腺炎患者产生额外的诊断价值。
{"title":"C‐reactive protein to LymphocytE count ratio could be a reliable mArkeR of thyroiditis; the CLEAR‐T study","authors":"M. Demirkol, G. Aktas","doi":"10.1002/prm2.12065","DOIUrl":"https://doi.org/10.1002/prm2.12065","url":null,"abstract":"Inflammation of the thyroid gland is referred to as thyroiditis and is associated with inflammation. Recent studies found significant association between thyroiditis and novel inflammatory and metabolic markers, as well as C‐reactive protein (CRP). CRP/lymphocyte count ratio (CLR) is a novel inflammatory marker that associated with various conditions and has not been studied in thyroiditis, yet. We aimed to investigate CRP to lymphocyte count ratio in patients with thyroiditis and to compare to those in healthy subjects. Patients with thyroiditis that presented to internal medicine outpatient clinics of our institution between January 2019 and August 2021 were enrolled to the retrospective study. Healthy volunteers were enrolled as control group. CLR of the thyroiditis and control groups were compared. Median CLR of the thyroiditis and control groups were 3.14 (0.14%–38)% and 0.4 (0.03–8.86)%, respectively (p < .001). The sensitivity and specificity of CLR > 0.43% in detecting thyroiditis were 92% and 58%, respectively (AUC: 0.88, p < .001, 95% CI: 0.85–0.92).CLR was significantly and positively correlated with free T4 (FT4) (r = .18, p < .001) and inversely correlated with thyroid stimulating hormone (TSH) (r = −.52, p = .003) levels. In conclusion, we suggest that high CLR levels may yield additional diagnostic value in patients with thyroiditis.","PeriodicalId":40071,"journal":{"name":"Precision Medical Sciences","volume":"11 1","pages":"31 - 34"},"PeriodicalIF":0.5,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48232140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
An exceptional prostate cancer case: Importance of cancer screening 一个特殊的前列腺癌病例:癌症筛查的重要性
IF 0.5 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2022-03-01 DOI: 10.1002/prm2.12063
Elif Basaran, N. Kucukoztas, Halit Oktay Aktepe, B. A. Atak Tel, G. Aktas
Prostate cancer is a common type of malignancy in male population. It may present with various clinical findings including urinary retention. Here, we present a prostate cancer case in an elderly man who investigated for the origin of long‐term fever and weight loss. A 69‐year‐old man presented to our institution for a fever lasting more than a month. He had no other signs of infection. He lost about 15 kg within 3 months. Total prostate‐specific antigen (PSA) measurement in serum and prostate biopsy revealed advanced prostate cancer. His complaints diminished with prostate cancer treatment. In conclusion, we suggest that prostate cancer should be kept in mind in the differential diagnosis of fever and weight loss in men over 50 years of age whether he is symptomatic or not.
前列腺癌是男性常见的恶性肿瘤。它可能表现为各种临床表现,包括尿潴留。在这里,我们报告了一位老年男性前列腺癌病例,他调查了长期发烧和体重减轻的原因。一名69岁男子因发烧一个多月来我院就诊。他没有其他感染的迹象。他在3个月内减掉了15公斤。血清和前列腺活检中总前列腺特异性抗原(PSA)检测显示晚期前列腺癌。前列腺癌治疗后,他的抱怨减少了。总之,我们建议在鉴别诊断50岁以上男性发热和体重减轻时,无论是否有症状,都应注意前列腺癌。
{"title":"An exceptional prostate cancer case: Importance of cancer screening","authors":"Elif Basaran, N. Kucukoztas, Halit Oktay Aktepe, B. A. Atak Tel, G. Aktas","doi":"10.1002/prm2.12063","DOIUrl":"https://doi.org/10.1002/prm2.12063","url":null,"abstract":"Prostate cancer is a common type of malignancy in male population. It may present with various clinical findings including urinary retention. Here, we present a prostate cancer case in an elderly man who investigated for the origin of long‐term fever and weight loss. A 69‐year‐old man presented to our institution for a fever lasting more than a month. He had no other signs of infection. He lost about 15 kg within 3 months. Total prostate‐specific antigen (PSA) measurement in serum and prostate biopsy revealed advanced prostate cancer. His complaints diminished with prostate cancer treatment. In conclusion, we suggest that prostate cancer should be kept in mind in the differential diagnosis of fever and weight loss in men over 50 years of age whether he is symptomatic or not.","PeriodicalId":40071,"journal":{"name":"Precision Medical Sciences","volume":"11 1","pages":"39 - 41"},"PeriodicalIF":0.5,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48455828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gambogic acid inhibits epithelial–mesenchymal transition in breast cancer cells through upregulation of SIRT1 expression in vitro 在体外实验中,藤黄酸通过上调SIRT1表达抑制乳腺癌细胞上皮-间质转化
IF 0.5 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2022-03-01 DOI: 10.1002/prm2.12057
Shi‐ye Jiang, Jun Yu, Ming-Ji Zhu, Xiao-mei Zhang, Yuan-ying Zhang, Qin Zhang, Qing Hu, Min-hao Lv
Gambogic acid (GA) is a natural product that selectively induces apoptosis of cancer cells in vitro with high efficiency and low toxicity. Our previous data have shown inhibitory effects of GA on breast cancer cells. However, the detailed mechanisms for GA remain largely unknown. This study aimed to investigate the effect of GA on TGF‐β1‐induced tumor invasion and EMT in MDA‐MB‐231 cells, and contribution of elevated SIRT1 to antitumor effects of GA. Human breast cell MDA‐MB‐231 and MDA‐MB‐231 were incubated with TGF‐β1 (100 ng/ml) and GA. Cell viability was determined by MTT assay, while tumor invasion was determined by Boyden chamber invasion assay. The mRNA levels of SIRT1 and TGF‐β1 were measured by quantitative real‐time polymerase chain reaction (qRT‐PCR). The protein expressions of SIRT1 and EMT‐associated mesenchymal marker Vimentin were measured by Western blotting. Interleukin‐6 (IL‐6) protein content was measured by enzyme linked immunosorbent assays (ELISAs). Our results showed that, GA showed decreased proliferation in MDA‐MB‐231 cells, especially in MDA‐MB‐231 cells with TGF‐β1 incubation. GA inhibited tumor invasion and EMT in TGF‐β1‐treated MDA‐MB‐231 cells. GA increased mRNA and protein expression of SIRT1 in MDA‐MB‐231 cells with and without TGF‐β1 treatment. SIRT1 mRNA level in MDA‐MB‐231 cells was increased by TGF‐β1 incubation and decreased by GA treatment. In addition, the production of IL‐6 was increased by TGF‐β1, and decreased by GA. In conclusion, GA inhibits tumor invasion and EMT in breast cancer, potentially through upregulating SIRT1 expression. This study provides a novel antitumor effect of GA in breast cancer.
藤黄酸(GA)是一种高效、低毒的体外选择性诱导癌细胞凋亡的天然产物。我们之前的数据显示了GA对乳腺癌细胞的抑制作用。然而,GA的详细机制在很大程度上仍然未知。本研究旨在探讨GA对TGF - β1诱导的MDA - MB - 231细胞的肿瘤侵袭和EMT的影响,以及升高的SIRT1在GA抗肿瘤作用中的作用。人乳腺细胞MDA‐MB‐231和MDA‐MB‐231用TGF‐β1 (100 ng/ml)和GA孵育。MTT法检测细胞活力,Boyden室侵袭法检测肿瘤侵袭程度。采用定量实时聚合酶链反应(qRT - PCR)检测SIRT1和TGF - β1 mRNA水平。Western blotting检测SIRT1和EMT相关间充质标志物Vimentin的蛋白表达。采用酶联免疫吸附法(elisa)测定白细胞介素- 6 (IL - 6)蛋白含量。结果表明,GA可抑制MDA - MB‐231细胞的增殖,尤其是TGF‐β1孵育的MDA‐MB‐231细胞。GA抑制TGF - β1处理的MDA - MB - 231细胞的肿瘤侵袭和EMT。在TGF - β1处理和未处理的MDA - MB - 231细胞中,GA增加了SIRT1 mRNA和蛋白的表达。TGF‐β1孵育后MDA‐MB‐231细胞中SIRT1 mRNA水平升高,GA处理后SIRT1 mRNA水平降低。此外,TGF - β1增加IL - 6的产生,GA减少IL - 6的产生。综上所述,GA可能通过上调SIRT1表达抑制乳腺癌的肿瘤侵袭和EMT。本研究提供了一种新的GA对乳腺癌的抗肿瘤作用。
{"title":"Gambogic acid inhibits epithelial–mesenchymal transition in breast cancer cells through upregulation of SIRT1 expression in vitro","authors":"Shi‐ye Jiang, Jun Yu, Ming-Ji Zhu, Xiao-mei Zhang, Yuan-ying Zhang, Qin Zhang, Qing Hu, Min-hao Lv","doi":"10.1002/prm2.12057","DOIUrl":"https://doi.org/10.1002/prm2.12057","url":null,"abstract":"Gambogic acid (GA) is a natural product that selectively induces apoptosis of cancer cells in vitro with high efficiency and low toxicity. Our previous data have shown inhibitory effects of GA on breast cancer cells. However, the detailed mechanisms for GA remain largely unknown. This study aimed to investigate the effect of GA on TGF‐β1‐induced tumor invasion and EMT in MDA‐MB‐231 cells, and contribution of elevated SIRT1 to antitumor effects of GA. Human breast cell MDA‐MB‐231 and MDA‐MB‐231 were incubated with TGF‐β1 (100 ng/ml) and GA. Cell viability was determined by MTT assay, while tumor invasion was determined by Boyden chamber invasion assay. The mRNA levels of SIRT1 and TGF‐β1 were measured by quantitative real‐time polymerase chain reaction (qRT‐PCR). The protein expressions of SIRT1 and EMT‐associated mesenchymal marker Vimentin were measured by Western blotting. Interleukin‐6 (IL‐6) protein content was measured by enzyme linked immunosorbent assays (ELISAs). Our results showed that, GA showed decreased proliferation in MDA‐MB‐231 cells, especially in MDA‐MB‐231 cells with TGF‐β1 incubation. GA inhibited tumor invasion and EMT in TGF‐β1‐treated MDA‐MB‐231 cells. GA increased mRNA and protein expression of SIRT1 in MDA‐MB‐231 cells with and without TGF‐β1 treatment. SIRT1 mRNA level in MDA‐MB‐231 cells was increased by TGF‐β1 incubation and decreased by GA treatment. In addition, the production of IL‐6 was increased by TGF‐β1, and decreased by GA. In conclusion, GA inhibits tumor invasion and EMT in breast cancer, potentially through upregulating SIRT1 expression. This study provides a novel antitumor effect of GA in breast cancer.","PeriodicalId":40071,"journal":{"name":"Precision Medical Sciences","volume":"11 1","pages":"14 - 22"},"PeriodicalIF":0.5,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43735994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The prognostic role of lymph node dissection counts in the management of renal cell carcinoma: A large international cohort study 淋巴结清扫计数在肾细胞癌治疗中的预后作用:一项大型国际队列研究
IF 0.5 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2022-03-01 DOI: 10.1002/prm2.12064
Feng Qi, Xiyi Wei, Xin Xia, Zongshi Qin, Xiao Li
The count of lymph node dissection (LND) has been confirmed as a prognostic indicator in various cancers while the correlation between LND counts and patient prognosis in renal cell carcinoma (RCC) was not fully studied. This research evaluated the link between LND counts and the prognosis of RCC patients. This study obtained RCC patients from the SEER database between 2010 and 2014. Univariate and multivariate Cox regression analyses were used to assess the predictive and prognostic value of LND. Besides, Kaplan–Meier (KM) survival analysis was used for survival analysis. Finally, 1264 patients were included in this study, which were divided into none LND groups (249), 1–3 LND groups (166), and 4 or more LND groups (549). Age, laterality, stage, M stage, and grade were statistically different among the three groups. In univariate Cox analysis, stage, M stage, T stage, and grade were significantly correlated with overall survival (OS). In multivariate Cox regression analysis, age, race, stage, T stage, and grade were used as independent prognostic factors. KM survival analysis revealed that grade, T stage, M stage, and stage were significantly correlated with OS. Subgroup analysis revealed that LND counts were not significantly associated with survival risk in subgroups with different clinical factors. The current North American population analysis revealed that age, race, stage, T stage, and grade may be used as independent prognostic factors for patients with RCC. Moreover, the increasing LND counts during surgery may not improve the tumor outcomes of RCC patients.
淋巴结清扫(LND)计数已被证实是各种癌症的预后指标,而肾细胞癌(RCC)中淋巴结清扫计数与患者预后之间的相关性尚未得到充分研究。本研究评估了肾细胞癌患者LND计数与预后之间的联系。本研究从SEER数据库中获取了2010年至2014年间的RCC患者。单变量和多变量Cox回归分析用于评估LND的预测和预后价值。此外,采用Kaplan–Meier(KM)生存分析进行生存分析。最后,1264名患者被纳入本研究,分为无LND组(249)、1-3个LND小组(166)和4个或更多个LND团体(549)。年龄、偏侧性、分期、M分期和年级在三组之间存在统计学差异。在单变量Cox分析中,分期、M分期、T分期和分级与总生存率(OS)显著相关。在多变量Cox回归分析中,年龄、种族、分期、T分期和分级被用作独立的预后因素。KM生存分析显示,分级、T分期、M分期和分期与OS显著相关。亚组分析显示,在具有不同临床因素的亚组中,LND计数与生存风险没有显著相关性。目前的北美人群分析显示,年龄、种族、分期、T分期和分级可作为RCC患者的独立预后因素。此外,手术期间LND计数的增加可能不会改善RCC患者的肿瘤预后。
{"title":"The prognostic role of lymph node dissection counts in the management of renal cell carcinoma: A large international cohort study","authors":"Feng Qi, Xiyi Wei, Xin Xia, Zongshi Qin, Xiao Li","doi":"10.1002/prm2.12064","DOIUrl":"https://doi.org/10.1002/prm2.12064","url":null,"abstract":"The count of lymph node dissection (LND) has been confirmed as a prognostic indicator in various cancers while the correlation between LND counts and patient prognosis in renal cell carcinoma (RCC) was not fully studied. This research evaluated the link between LND counts and the prognosis of RCC patients. This study obtained RCC patients from the SEER database between 2010 and 2014. Univariate and multivariate Cox regression analyses were used to assess the predictive and prognostic value of LND. Besides, Kaplan–Meier (KM) survival analysis was used for survival analysis. Finally, 1264 patients were included in this study, which were divided into none LND groups (249), 1–3 LND groups (166), and 4 or more LND groups (549). Age, laterality, stage, M stage, and grade were statistically different among the three groups. In univariate Cox analysis, stage, M stage, T stage, and grade were significantly correlated with overall survival (OS). In multivariate Cox regression analysis, age, race, stage, T stage, and grade were used as independent prognostic factors. KM survival analysis revealed that grade, T stage, M stage, and stage were significantly correlated with OS. Subgroup analysis revealed that LND counts were not significantly associated with survival risk in subgroups with different clinical factors. The current North American population analysis revealed that age, race, stage, T stage, and grade may be used as independent prognostic factors for patients with RCC. Moreover, the increasing LND counts during surgery may not improve the tumor outcomes of RCC patients.","PeriodicalId":40071,"journal":{"name":"Precision Medical Sciences","volume":"11 1","pages":"23 - 30"},"PeriodicalIF":0.5,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46384863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Precision Medical Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1